Monday, March 24, 2025

TOPICS

Home Tags Pharmacy benefit managers

Tag: pharmacy benefit managers

New R.I. law protects patients who rely on specialty infusion drugs

Specialty drugs might come in a delicate glass vial in the mail, shipped by a specialty pharmacy in a styrofoam carton cushioned with ice...
CVS HEALTH CORP. released a report last week pushing back on accusations that the company and its peers reap excessive profits as they negotiate drug prices on behalf of clients such as insurers. / BLOOMBERG NEWS FILE PHOTO/CHRISTOPHER LEE

Opinion: CVS’ drug-price plan lets pharma off too easy

NEW YORK - The pharmacy benefit management business is under attack. And these middlemen of the arcane United States drug-pricing system are preparing their...

Trump plan to lower drug prices moves forward on several fronts

NEW YORK - The Trump administration moved swiftly in the past 24 hours to implement pieces of its plan to bring down drug prices, taking...
ALEX AZAR, secretary of Health and Human Services, speaks during a press briefing at the White House after an event on lowering drug prices with President Donald Trump. / BLOOMBERG FILE PHOTO/ANDREW HARRER

Trump health secretary says drugmakers must help cut prices

NEW YORK - President Donald Trump’s top health official said the administration plans to turn up the heat on the pharmaceutical industry if it doesn’t...
THREE PHARMACY-BENEFIT MANAGERS - CVS Health, Express Scripts and UnitedHealthcare - control more than 70 percent of the market, including more than half of the $138 billion specialty drug prescription market.

Partners turned into prey as insurers, drug plans get squeezed

NEW YORK – Over 20 years, Brian Komoto built a thriving pharmacy in California’s Central Valley. Each day, his nurses would travel the vast...
CVS HEALTH'S pharmacy benefit management business came under fire, along with other PBMs, from the head of the Food and Drug Administration for holding drug prices artificially high. / BLOOMBERG FILE PHOTO/MICHAEL NAGLE

`Rigged’ system blocks use of lower-cost drugs, FDA chief says

WASHINGTON – A “rigged payment scheme” between drug plans, insurers and pharmaceutical companies has blocked access to less-expensive versions of some of the most costly drugs...

Drug middlemen have slim profit margins — Just ask them

  NEW YORK - Companies of all kinds try to present their financial results in the best light possible to attract investors. One segment of the...
- Featured Event -

Latest News